查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927707

全球黴漿菌檢測市場：依產品類型、技術、檢測類型、應用、國家及地區分類－產業分析、市場規模、佔有率及預測（2025-2032年）

Mycoplasma Testing Market, By Product Type, By Technology, By Test Type, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，黴漿菌檢測市場規模將達到 14.5254 億美元，從 2025 年到 2032 年，複合年成長率將達到 12.01%。

黴漿菌檢測用於檢測和定量細胞培養、生物製藥和藥物中的黴漿菌污染，以確保產品安全性並符合監管標準。對生物製藥、疫苗和細胞療法日益成長的需求正在推動研發和生產實驗室採用黴漿菌檢測解決方案。快速、靈敏的檢測方法和自動化檢測平台的發展具有巨大的潛力，它們可以縮短檢測時間並提高檢測準確性，對於大規模生物製藥生產的品質控制至關重要。一個顯著的趨勢是將分子和PCR技術與傳統培養方法結合，以提高檢測可靠性並最大限度地減少假陰性結果。然而，黴漿菌檢測的複雜性和檢測靈敏度的差異性帶來了挑戰，限制了其在小規模實驗室和需要超快速、高通量檢測的應用中的使用。

黴漿菌檢測市場動態

生物製藥和細胞治療生產中對污染控制的需求日益成長

生物製藥、疫苗和細胞療法的日益普及推動了對黴漿菌檢測解決方案的顯著需求。黴漿菌檢測在確保這些產品的安全性、品質和合規性方面發揮著至關重要的作用。隨著生物製藥和治療性細胞株生產的擴大，迫切需要快速可靠的黴漿菌檢測方法來防止可能損害產品療效和病人安全的污染。高通量、自動化檢測平台的發展趨勢進一步增加了需求，因為它們能夠提供更快的檢測結果、更穩定的準確性，並能整合到現代生物製造工作流程中。此外，全球生物製藥生產的持續成長，尤其是在北美和歐洲等地區，也顯著推動了對靈敏且標準化的黴漿菌檢測的需求。例如，根據最新的2024年數據，超過75%的生物製藥生產商將對所有細胞生產線進行常規黴漿菌檢測。基因和細胞療法的日益普及也推動了對強力的污染監測的需求，以維持嚴格的品質標準。

黴漿菌檢測市場：細分分析

全球黴漿菌檢測市場按產品類型、技術、檢測類型、應用和地區進行細分。

根據產品類型，市場可分為三大類：黴漿菌檢測試劑盒、試劑和檢測方法以及參考標準品。這些試劑盒提供快速、標準化且經過驗證的解決方案，可減少檢驗流程的時間和人力投入。試劑和檢測方法排名第二。它們對於客製化檢測通訊協定至關重要，支援手動和自動化檢測平台，並為基於分子和培養的檢測方法提供高靈敏度和特異性。參考標準品緊隨其後，提供關鍵的品管和校準材料，以確保檢測的準確性、符合法規要求以及實驗室間的可重複性。整體而言，市場優先順序反映了對可靠、高效且檢驗的檢測解決方案的需求，這些解決方案能夠保障產品品質並滿足嚴格的法規標準。

根據技術，市場可分為四個細分領域：基於PCR的檢測、ELISA、DNA染色和微生物培養。基於PCR的檢測憑藉其高靈敏度、快速出結果以及在品管和污染監測工作流程中的廣泛應用，佔據市場主導地位。 ELISA排名第二，以其強大的抗原抗體檢測能力以及適用於高通量篩檢和品管流程而聞名。 DNA染色主要用於研究和專業實驗室應用，以目視方式檢測黴漿菌污染，但與分子方法相比，其靈敏度較低且操作繁瑣。微生物培養排名墊底。雖然它是黴漿菌檢測的傳統黃金標準，但其處理速度慢、需要專業知識且通量低，限制了其在現代對時間要求嚴格的生產環境中的應用。總體而言，市場優先考慮的是準確性、速度以及與自動化工作流程的整合。

黴漿菌檢測市場—區域分析

黴漿菌檢測市場呈現明顯的區域趨勢。北美地區憑藉其強大的生物製藥產業、先進的實驗室基礎設施以及嚴格的污染控制監管要求，佔據了約38-40%的市場佔有率，並推動了全球需求。美國是北美市場的主要主導力量，因為主要的治療藥物和疫苗生產商已將黴漿菌檢測納入其品管通訊協定。歐洲市場佔有率位居第二，德國、英國和法國等國的監管協調和生物技術研究的拓展推動了快速檢測解決方案的普及。亞太地區是成長最快的市場，這主要得益於中國、印度和日本不斷擴大的製藥生產以及對自動化檢測系統投資的增加。策略發展正在增強區域市場的成長勢頭，例如生物梅里埃公司於2024年5月與Anabiotek公司合作開發創新的黴漿菌調查方法。主要企業在全球的推廣活動也提高了試劑盒和服務的可及性。

黴漿菌檢測市場—國家分析

從國家層級來看，美國是黴漿菌檢測的領先市場。這主要得益於美國大規模的生物製藥產業、嚴格的監管污染標準以及廣泛的研發活動，這些因素共同促成了先進檢測解決方案的高普及率。到2024年，北美整體將佔據全球近一半的市場佔有率，其中美國是最大的貢獻者。在歐洲，德國、英國和法國等國家也是重要的市場貢獻者，這得益於其強大的研究基礎設施和生物製藥生產中廣泛的污染控制舉措。以中國、日本和印度主導的亞太地區正隨著藥品產量的成長和品管投入的增加而快速擴張。尤其值得一提的是，由於國內生物技術活動的活躍，中國市場預計將實現強勁成長。諸如bioMérieux與Anabiotek於2024年合作改善黴漿菌檢測方法等策略合作，將進一步推動各國的能力提升與創新。

目錄

第1章黴漿菌檢測市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章黴漿菌檢測市場主要趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章黴漿菌檢測市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章黴漿菌檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章黴漿菌檢測市場現狀

  • 黴漿菌檢測市佔率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 依產品類型黴漿菌檢測市場

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 黴漿菌檢測試劑盒
    • 試劑和測定
    • 參考標準物質

第8章黴漿菌檢測市場（依技術分類）

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 基於PCR的檢測
    • ELISA
    • DNA染色方法
    • 微生物培養法

第9章黴漿菌檢測市場（依檢測類型分類）

  • 概述
    • 細分市場佔有率分析：依測試類型
    • 定性測試
    • 定量測試

第10章黴漿菌檢測市場（依應用領域分類）

  • 概述
    • 細分市場佔有率分析：按應用
    • 細胞株檢測
    • 疫苗生產試驗
    • 生物製藥生產
    • 臨床診斷

第11章黴漿菌檢測市場（按地區分類）

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－黴漿菌檢測產業

  • 競爭對手儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Agilent Technologies
    • ATCC
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories
    • Charles River Laboratories
    • Creative Diagnostics
    • Eurofins Scientific
    • Fujifilm Irvine Scientific
    • Hologic
    • InvivoGen
    • Lonza Group
    • Merck KGaA
    • Meridian Bioscience
    • Minerva Biolabs
    • PromoCell
    • QIAGEN
    • Roche Diagnostics
    • Sigma-Aldrich
    • Takara Bio
    • Thermo Fisher Scientific
    • Others

第13章：分析師的全方位展望

簡介目錄
Product Code: ANV5963

Mycoplasma Testing Market size was valued at US$ 1,452.54 Million in 2024, expanding at a CAGR of 12.01% from 2025 to 2032.

Mycoplasma testing involves detecting and quantifying Mycoplasma contamination in cell cultures, biologics, and pharmaceutical products to ensure product safety and compliance with regulatory standards. The growing demand for biologics, vaccines, and cell-based therapies is driving the adoption of Mycoplasma testing solutions across research and manufacturing laboratories. Opportunities exist in developing rapid, high-sensitivity assays and automated testing platforms that reduce turnaround times and enhance detection accuracy, which is critical for maintaining quality in large-scale biopharmaceutical production. A prominent trend is the integration of molecular and PCR-based techniques with traditional culture methods to improve reliability while minimizing false negatives. However, the complexity of Mycoplasma detection and variability in test sensitivity pose challenges, limiting adoption in small-scale laboratories and in applications requiring ultra-rapid or high-throughput testing.

Mycoplasma Testing Market- Market Dynamics

Rising demand for contamination control in biopharmaceutical and cell therapy production

The growing adoption of biopharmaceuticals, vaccines, and cell-based therapies is significantly driving the demand for Mycoplasma testing solutions, which play a critical role in ensuring the safety, quality, and regulatory compliance of these products. As manufacturers increasingly scale up production of biologics and therapeutic cell lines, there is a pressing need for rapid and reliable Mycoplasma detection methods to prevent contamination that can compromise product efficacy and patient safety. The trend toward high-throughput and automated testing platforms is further increasing demand, as these solutions enable faster results, consistent accuracy, and integration into modern bio manufacturing workflows. Moreover, the continuous growth in global biologics production, particularly in regions such as North America and Europe, is significantly driving the requirement for sensitive and standardized Mycoplasma testing. For instance, recent data from 2024 indicates that over 75 percent of biopharmaceutical manufacturers perform routine Mycoplasma testing across all cell-based production lines. The expanding use of gene and cell therapies is also intensifying the need for robust contamination monitoring to maintain stringent quality standards.

Mycoplasma Testing Market- Segmentation Analysis:

The Global Mycoplasma Testing Market is segmented on the basis of Product Type, Technology, Test Type, Application, and Region.

The market is segmented into three categories based on product type: Mycoplasma detection kits, reagents & assays, and reference standards. These kits offer rapid, standardized, and validated solutions, reducing time and labor in testing workflows. Reagents & Assays rank second, as they are essential for customizing detection protocols, supporting both manual and automated testing platforms, and enabling higher sensitivity and specificity in molecular and culture-based detection methods. Reference Standards follow, providing critical quality controls and calibration materials to ensure assay accuracy, regulatory compliance, and reproducibility across laboratories. Overall, the market prioritization reflects the need for reliable, efficient, and validated testing solutions that safeguard product quality and meet stringent regulatory standards.

The market is categorized into four segments based on technology: PCR-based testing, ELISA, DNA staining, and microbial culture methods. The PCR-based testing segment leads the market, driven by its high sensitivity, rapid turnaround, and broad adoption in quality control and contamination monitoring workflows. ELISA ranks second, valued for its robust antigen-antibody detection capabilities and applicability in high-throughput screening and quality control processes. DNA Staining follows, used primarily in research and specialized laboratory applications to detect mycoplasma contamination visually, though it is less sensitive and labor-intensive compared to molecular methods. Microbial Culture Methods rank last, as they remain the traditional standard for mycoplasma detection but are slower, require specialized expertise, and have lower throughput, limiting their use in modern, time-sensitive production environments. Overall, prioritization reflects accuracy, speed, and integration with automated workflow.

Mycoplasma Testing Market- Geographical Insights

The Mycoplasma Testing Market shows distinct regional dynamics, with North America leading global demand due to its robust biopharmaceutical industry, advanced laboratory infrastructure, and strict regulatory requirements for contamination control, accounting for about 38-40% of the market share. The United States drives this dominance as major therapeutic and vaccine manufacturers routinely implement mycoplasma testing in quality control protocols. Europe holds the second-largest share, supported by harmonized regulations and expanded biotechnology research in countries such as Germany, the UK, and France, which boosts the adoption of rapid detection solutions. The Asia-Pacific region is the fastest-growing market, propelled by expanding pharmaceutical production in China, India, and Japan and increasing investments in automated testing systems. Strategic developments reinforce regional momentum; for example, bioMerieux partnered with AnaBioTec in May 2024 to advance innovative mycoplasma testing methodologies, and global expansion initiatives by major players are increasing accessibility of kits and services.

Mycoplasma Testing Market- Country Insights

At the country level, the United States is the foremost market for mycoplasma testing, driven by its substantial biopharmaceutical industry, stringent regulatory contamination standards, and extensive R&D activity, which collectively lead to high adoption of advanced testing solutions. North America overall accounted for nearly half of the global market in 2024, with the U.S. as the primary contributor. In Europe, countries such as Germany, the United Kingdom, and France are significant contributors, supported by strong research infrastructure and widespread contamination control initiatives in biologics manufacturing. The Asia-Pacific region, led by China, Japan, and India, is expanding rapidly as pharmaceutical production increases and investment in quality control rises, with China's market projected to grow strongly due to robust domestic biotech activity. Strategic collaborations, such as bioMerieux's 2024 partnership with AnaBioTec to enhance mycoplasma detection methods, further advance country-level capabilities and innovation.

Mycoplasma Testing Market- Competitive Landscape:

The competitive landscape of the Mycoplasma Testing Market is shaped by a mix of established life science firms and specialized diagnostics providers focused on contamination detection solutions. Key players such as Merck KGaA, bioMerieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., and Charles River Laboratories International Inc. compete on the basis of test accuracy, speed, automation compatibility, and global distribution networks. Companies are investing in assay development, automation integration, and expanded service offerings to strengthen market positions. Strategic transactions are actively reshaping competition; for instance, bioMerieux's partnership with AnaBioTec in 2024 aims to co-develop enhanced mycoplasma detection technologies, while Thermo Fisher Scientific's acquisition of Qiagen's Cell Culture and Molecular Diagnostics Business (completed in 2023) expanded its infectious disease and contamination testing portfolio, including mycoplasma solutions. Ongoing collaborations with contract research organizations and genomic service providers further extend the reach of testing platforms, supporting broad adoption in biopharmaceutical manufacturing and research environments. Overall, competitive dynamics prioritize innovation, regulatory compliance, and comprehensive testing solutions.

Recent Developments:

In September 2025, Fuse Diagnostics launched its Flip Mycoplasma rapid mycoplasma contamination test across major European countries through a distribution agreement with CliniSciences, enabling ultra-rapid, simple cell culture quality screening without complex equipment.

Agathos Biologics stated in April 2023 that it would provide life science researchers with analytical testing services. Agathos only uses QIAGEN-developed QIAcuity equipment and assays. Additionally, Agathos and QIAGEN have partnered to test and validate mycoplasma and recombinant adeno-associated viral vector (rAAV) assays.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MYCOPLASMA TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Agilent Technologies
  • ATCC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Charles River Laboratories
  • Creative Diagnostics
  • Eurofins Scientific
  • Fujifilm Irvine Scientific
  • Hologic
  • InvivoGen
  • Lonza Group
  • Merck KGaA
  • Meridian Bioscience
  • Minerva Biolabs
  • PromoCell
  • QIAGEN
  • Roche Diagnostics
  • Sigma-Aldrich
  • Takara Bio
  • Thermo Fisher Scientific
  • Others

GLOBAL MYCOPLASMA TESTING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Mycoplasma Detection Kits
  • Reagents & Assays
  • Reference Standards

GLOBAL MYCOPLASMA TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR-Based Testing
  • ELISA
  • DNA Staining
  • Microbial Culture Methods

GLOBAL MYCOPLASMA TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Qualitative Testing
  • Quantitative Testing

GLOBAL MYCOPLASMA TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cell Line Testing
  • Vaccine Production Testing
  • Biopharmaceutical Manufacturing
  • Clinical Diagnostics

GLOBAL MYCOPLASMA TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mycoplasma Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mycoplasma Testing Market Snippet by Product Type
    • 2.1.2. Mycoplasma Testing Market Snippet by Technology
    • 2.1.3. Mycoplasma Testing Market Snippet by Test Type
    • 2.1.4. Mycoplasma Testing Market Snippet by Application
    • 2.1.5. Mycoplasma Testing Market Snippet by Country
    • 2.1.6. Mycoplasma Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Mycoplasma Testing Key Market Trends

  • 3.1. Mycoplasma Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mycoplasma Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mycoplasma Testing Market Opportunities
  • 3.4. Mycoplasma Testing Market Future Trends

4. Mycoplasma Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mycoplasma Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mycoplasma Testing Market Landscape

  • 6.1. Mycoplasma Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mycoplasma Testing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Mycoplasma Detection Kits
    • 7.1.3. Reagents & Assays
    • 7.1.4. Reference Standards

8. Mycoplasma Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. PCR-Based Testing
    • 8.1.3. ELISA
    • 8.1.4. DNA Staining
    • 8.1.5. Microbial Culture Methods

9. Mycoplasma Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 9.1.2. Qualitative Testing
    • 9.1.3. Quantitative Testing

10. Mycoplasma Testing Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Cell Line Testing
    • 10.1.3. Vaccine Production Testing
    • 10.1.4. Biopharmaceutical Manufacturing
    • 10.1.5. Clinical Diagnostics

11. Mycoplasma Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Mycoplasma Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Mycoplasma Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Mycoplasma Testing Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Mycoplasma Testing Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Mycoplasma Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Mycoplasma Testing Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Agilent Technologies
    • 12.2.2. ATCC
    • 12.2.3. Becton, Dickinson and Company
    • 12.2.4. Bio-Rad Laboratories
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Creative Diagnostics
    • 12.2.7. Eurofins Scientific
    • 12.2.8. Fujifilm Irvine Scientific
    • 12.2.9. Hologic
    • 12.2.10. InvivoGen
    • 12.2.11. Lonza Group
    • 12.2.12. Merck KGaA
    • 12.2.13. Meridian Bioscience
    • 12.2.14. Minerva Biolabs
    • 12.2.15. PromoCell
    • 12.2.16. QIAGEN
    • 12.2.17. Roche Diagnostics
    • 12.2.18. Sigma-Aldrich
    • 12.2.19. Takara Bio
    • 12.2.20. Thermo Fisher Scientific
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us